Healthcare
Live Price
Offline$11.52
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sawai Group Holdings Co., Ltd. (SWGHF) is a Healthcare stock with a market cap of $238.59B and listed on OTC. The stock last traded around $11.52 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +6.9%, EPS growth of -40.8%, a dividend yield of 2.7%. What stands out right now is revenue +6.9%, EPS -40.8%, free cash flow +122.5% with operating margin 9.3% and ROIC 2.6%. The dividend matters to the case here, with a current yield around 2.7%. Valuation is more restrained than many high-expectation growth names at price/sales 1.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SWGHF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SWGHF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SWGHF Max Drawdown
-4.24%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SWGHF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$187.2B
-3.4% YoY
FY Net Income
$12.3B
+143.7% YoY
Free Cash Flow
$10.7B
-2.1% YoY
Revenue Growth
+6.9%
EPS Growth
-40.8%
Gross Margin
28.9%
Net Margin
-1.4%
Income statement
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 189.0B | 176.9B | 200.3B | 193.8B | 187.2B |
| Gross Profit | 56.4B | 54.3B | 62.6B | 66.7B | 72.4B |
| Operating Income | 20.8B | 18.6B | 16.4B | -4.5B | 18.9B |
| EBITDA | 36.2B | 36.9B | 33.9B | -18.7B | 41.2B |
| Net Income | 22.9B | 13.7B | 12.7B | -28.3B | 12.3B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 38.8B | 26.4B | 33.1B | 47.7B | 54.3B |
| Total Assets | 354.6B | 382.0B | 364.2B | 349.5B | 393.3B |
| Total Liabilities | 180.8B | 164.0B | 151.4B | 149.4B | 152.6B |
| Shareholder Equity | 173.9B | 212.7B | 201.6B | 190.1B | 218.3B |
| Total Debt | 91.3B | 82.9B | 77.1B | 71.2B | 71.9B |
| Net Debt | 52.6B | 56.5B | 44.0B | 23.1B | 17.6B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
31.9B
-7.1% YoY
Capital Expenditures
21.1B
+9.5% YoY
Free Cash Flow
10.7B
-2.1% YoY
Key ratios
Gross Margin
28.9%
Operating Margin
9.3%
Net Margin
-1.4%
ROE
-1.6%
Debt / Equity
0.69x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.